Literature DB >> 18791464

High glucose concentration increases macrophage cholesterol biosynthesis in diabetes through activation of the sterol regulatory element binding protein 1 (SREBP1): inhibitory effect of insulin.

Marielle Kaplan1, Rachel Kerry, Michael Aviram, Tony Hayek.   

Abstract

Diabetes activates atherogenesis and macrophage foam cell formation. This study's goal was to determine whether insulin counteracts diabetes-induced macrophage foam cell formation, as well as to determine transcriptional mechanisms involved in this effect.Insulin injection to diabetic mice reduced macrophage lipid peroxides levels, Ox-LDL uptake, and CD36 mRNA levels by 40%, 29%, and by 41% respectively, compared to age-matched untreated diabetic mice. These results were further assessed using an in vitro system. Addition of insulin to glucose-enriched cells led to a significant decrease in cellular lipid peroxidation by 43% compared to cells incubated with high concentrations of glucose with no insulin. This effect was correlated with a reduction in NADPH oxidase activity.Macrophage cholesterol biosynthesis was then studied in cells from diabetic mice treated with insulin and in glucose-enriched macrophages incubated with insulin. Insulin treatment of diabetic mice significantly reduced macrophage cholesterol biosynthesis, HMG-CoA reductase mRNA expression, and protein expression by 81%, 54%, and 31% respectively, compared to macrophages isolated from nontreated diabetic mice. Similarly, insulin incubation with glucose-enriched macrophages significantly reduced macrophage cholesterol biosynthesis, HMG-CoA reductase mRNA expression, and protein expression by 84%, 42%, and 18%, respectively, compared to macrophages incubated with high glucose but without insulin. These effects were mediated by glucose and insulin ability to regulate the transcription factor SREBP-1. Whereas glucose upregulated SREBP-1 expression and maturation, insulin blocked SREBP1 cleavage, leading to reduced mature form of the transcription factor in the nucleus.In conclusion, this study presents important novel insights on the events connecting diabetes and glucose stimulation of macrophage foam cell formation leading to atherosclerosis. Most important, the inhibitory effects of insulin on diabetes-mediated (and high glucose-induced) increased cholesterol synthesis were shown to involve modulation of SREBP-1 expression and its maturation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18791464     DOI: 10.1097/FJC.0b013e3181879d98

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  10 in total

1.  Role of pyruvate kinase M2 in oxidized LDL-induced macrophage foam cell formation and inflammation.

Authors:  Amit Kumar; Priya Gupta; Minakshi Rana; Tulika Chandra; Madhu Dikshit; Manoj Kumar Barthwal
Journal:  J Lipid Res       Date:  2020-01-27       Impact factor: 5.922

2.  Vitamin D and Evening Primrose Oil Administration Improve Glycemia and Lipid Profiles in Women with Gestational Diabetes.

Authors:  Mehri Jamilian; Maryam Karamali; Mohsen Taghizadeh; Nasrin Sharifi; Zahra Jafari; Mohammad Reza Memarzadeh; Mahnaz Mahlouji; Zatolla Asemi
Journal:  Lipids       Date:  2016-01-19       Impact factor: 1.880

3.  Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype.

Authors:  Alex J Freemerman; Amy R Johnson; Gina N Sacks; J Justin Milner; Erin L Kirk; Melissa A Troester; Andrew N Macintyre; Pankuri Goraksha-Hicks; Jeffery C Rathmell; Liza Makowski
Journal:  J Biol Chem       Date:  2014-02-03       Impact factor: 5.157

4.  Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth.

Authors:  Chunming Cheng; Peng Ru; Feng Geng; Junfeng Liu; Ji Young Yoo; Xiaoning Wu; Xiang Cheng; Vanessa Euthine; Peng Hu; Jeffrey Yunhua Guo; Etienne Lefai; Balveen Kaur; Axel Nohturfft; Jianjie Ma; Arnab Chakravarti; Deliang Guo
Journal:  Cancer Cell       Date:  2015-11-09       Impact factor: 31.743

Review 5.  Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy.

Authors:  Sandra Rayego-Mateos; José Luis Morgado-Pascual; Lucas Opazo-Ríos; Melania Guerrero-Hue; Cristina García-Caballero; Cristina Vázquez-Carballo; Sebastián Mas; Ana Belén Sanz; Carmen Herencia; Sergio Mezzano; Carmen Gómez-Guerrero; Juan Antonio Moreno; Jesús Egido
Journal:  Int J Mol Sci       Date:  2020-05-27       Impact factor: 5.923

6.  Analysis of the Glucose-Dependent Transcriptome in Murine Hypothalamic Cells.

Authors:  Leonhard Webert; Dennis Faro; Sarah Zeitlmayr; Thomas Gudermann; Andreas Breit
Journal:  Cells       Date:  2022-02-11       Impact factor: 6.600

7.  AAV-mediated administration of myostatin pro-peptide mutant in adult Ldlr null mice reduces diet-induced hepatosteatosis and arteriosclerosis.

Authors:  Wen Guo; Siu Wong; Shalender Bhasin
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

8.  Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice.

Authors:  Michishige Terasaki; Munenori Hiromura; Yusaku Mori; Kyoko Kohashi; Masaharu Nagashima; Hideki Kushima; Takuya Watanabe; Tsutomu Hirano
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

Review 9.  Immune Cells and Inflammation in Diabetic Nephropathy.

Authors:  Zihan Zheng; Feng Zheng
Journal:  J Diabetes Res       Date:  2015-12-28       Impact factor: 4.011

10.  The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization.

Authors:  Majid Dastorani; Esmat Aghadavod; Naghmeh Mirhosseini; Fatemeh Foroozanfard; Shahrzad Zadeh Modarres; Mehrnush Amiri Siavashani; Zatollah Asemi
Journal:  Reprod Biol Endocrinol       Date:  2018-10-04       Impact factor: 5.211

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.